Apg Asset Management N.V. Vertex Pharmaceuticals Inc Transaction History

Apg Asset Management N.V.

$15.7 Billion
Q3 2024

A detailed history of Apg Asset Management N.V. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Apg Asset Management N.V. holds 124,020 shares of VRTX stock, worth $57.8 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

124,020

Previous 357,884 65.35%

Holding current value

$57.8 Million

Previous $168 Million 65.62%

% of portfolio

0.37%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$460.0 - $505.78 $108 Million - $118 Million	-233,864 Reduced 65.35%	124,020 $57.7 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $19.7 Million - $24.4 Million	50,190 Added 16.31%	357,884 $168 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $14.3 Million - $15.6 Million	-35,000 Reduced 10.21%	307,694 $129 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $14.5 Million - $17.4 Million	42,398 Added 14.12%	342,694 $139 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $8.85 Million - $9.48 Million	-26,160 Reduced 8.01%	300,296 $104 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $8.22 Million - $9.2 Million	-26,152 Reduced 7.42%	326,456 $115 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $18.7 Million - $21.3 Million	-66,034 Reduced 15.77%	352,608 $111 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $29.3 Million - $33 Million	-102,647 Reduced 19.69%	418,642 $121 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $81.9 Million - $91.4 Million	-299,066 Reduced 36.46%	521,289 $154 Million
Q2 2022 Aug 12, 2022	SELL	$234.96 - $292.55 $79.1 Million - $98.5 Million	-336,534 Reduced 29.09%	820,355 $221 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $11 Million - $13 Million	-49,700 Reduced 4.12%	1,156,889 $271 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $3.91 Million - $4.94 Million	-22,100 Reduced 1.8%	1,206,589 $233 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $8.51 Million - $9.52 Million	-46,900 Reduced 3.68%	1,228,689 $192 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $5.3 Million - $6.25 Million	28,250 Added 2.26%	1,275,589 $217 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $10.9 Million - $12.8 Million	-52,882 Reduced 4.07%	1,247,339 $228 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $136 Million - $181 Million	655,929 Added 101.81%	1,300,221 $251 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $281,215 - $333,410	1,100 Added 0.17%	644,292 $150 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $103 Million - $135 Million	457,871 Added 247.07%	643,192 $166 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $25 Million - $31 Million	125,124 Added 207.86%	185,321 $44.1 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $405,533 - $503,054	2,030 Added 3.49%	60,197 $9.86 Million
Q4 2019 Feb 13, 2020	SELL	$166.71 - $223.91 $3.21 Million - $4.32 Million	-19,279 Reduced 24.89%	58,167 $11.3 Million
Q3 2019 Nov 08, 2019	SELL	$166.23 - $187.09 $706,643 - $795,319	-4,251 Reduced 5.2%	77,446 $12 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $3.54 Million - $4.09 Million	21,500 Added 35.72%	81,697 $13.2 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $698,786 - $884,166	-4,600 Reduced 7.1%	60,197 $8.73 Million
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $2.9 Million - $3.33 Million	-17,300 Reduced 21.07%	64,797 $10.8 Million
Q2 2018 Aug 13, 2018	SELL	$145.72 - $169.96 $1.84 Million - $2.14 Million	-12,600 Reduced 13.31%	82,097 $12 Million
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $11.2 Million - $13.1 Million	-73,900 Reduced 43.83%	94,697 $12.5 Million
Q4 2017 Jan 24, 2018	BUY	$137.28 - $155.55 $12.4 Million - $14.1 Million	90,529 Added 115.96%	168,597 $21 Million
Q3 2017 Oct 19, 2017	BUY	$148.13 - $162.24 $11.6 Million - $12.7 Million	78,068	78,068 $11.9 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Vertex Pharmaceuticals Inc Transaction History